The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10087 malaria professionals are enjoying the free benefits of MalariaWorld today

artemisinin-based combination therapy (ACT)

Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries

August 30, 2017 - 17:21 -- Open Access
Tags: 
Author(s): 
Joël Ladner, Ben Davis, Etienne Audureau and Joseph Saba
Reference: 
Malaria Journal 2017 16:353, 29 August 2017

This study highlights differences in drug prescription and purchase patterns in five sub-Saharan African countries.

Household beliefs about malaria testing and treatment in Western Kenya: the role of health worker adherence to malaria test results

August 30, 2017 - 16:26 -- Open Access
Tags: 
Author(s): 
Indrani Saran, Elisa M. Maffioli, Diana Menya and Wendy Prudhomme O’Meara
Reference: 
Malaria Journal 2017 16:349, 22 August 2017

Individuals/caregivers were more likely to believe that the illness was malaria when the patient was treated with ACT, regardless of their test result.

Country: 

Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009–2013)

August 15, 2017 - 14:40 -- Open Access
Author(s): 
Myat Htut Nyunt, Myat Thu Soe, Hla Win Myint, Htet Wai Oo, Moe Moe Aye, Soe Soe Han, Ni Ni Zaw, Cho Cho, Phyo Zaw Aung, Khin Thiri Kyaw, Thin Thin Aye, Naychi Aung San, Leonard Ortega, Krongthong Thimasarn, Maria Dorina G. Bustos, Sherwin Galit…
Reference: 
Malaria Journal 2017 16:333, 14 August 2017

Apart from k13, pfarps10, pffd and pfmdr2 are also useful for molecular surveillance of artemisinin resistance especially where k13 mutation has not been reported.

Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar

August 15, 2017 - 14:38 -- Open Access
Author(s): 
Abdullah S. Ali, Narjis G. Thawer, Bakar Khatib, Haji H. Amier, Joseph Shija, Mwinyi Msellem, Abdul-wahid Al-mafazy, Issa A. Garimo, Humphrey Mkali, Mahdi M. Ramsan, Jessica M. Kafuko, Lynn A. Paxton, Richard Reithinger and Jeremiah M. Ngondi
Reference: 
Malaria Journal 2017 16:332, 14 August 2017

Mass drug administration for malaria was well accepted by communities at high risk of malaria in Zanzibar, with high participation and completion rates.

School-based diagnosis and treatment of malaria by teachers using rapid diagnostic tests and artemisinin-based combination therapy: experiences and perceptions of users and implementers of the Learner Treatment Kit, southern Malawi

August 9, 2017 - 15:30 -- Open Access
Tags: 
Author(s): 
Treza Mphwatiwa, Stefan Witek-McManus, Don P. Mathanga, et al.
Reference: 
Malaria Journal 2017 16:318, 7 August 2017

Training teachers to test for and treat uncomplicated malaria in schools was well received by both users and implementers alike, and was perceived by the majority of stakeholders to be a valuable programme.

Country: 

Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis

August 8, 2017 - 11:01 -- Open Access
Tags: 
Author(s): 
Solange Whegang Youdom, Rachida Tahar and Leonardo K. Basco
Reference: 
Malaria Journal 2017 16:311, 3 August 2017

Based on the available evidence, this study demonstrated the superiority of DHAP among currently recommended artemisinin-based combinations. The

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries

May 25, 2017 - 14:38 -- Open Access
Tags: 
Author(s): 
Paul N. Newton, Kara Hanson and Catherine Goodman
Reference: 
Malaria Journal 2017 16:204, 25 May 2017

Addressing the availability and distribution of non-QAACT will require effective private sector engagement and evidence-based strategies to address provider and consumer demand for these products.

Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria

May 23, 2017 - 18:07 -- Open Access
Tags: 
Author(s): 
Michael Nambozi, Jean-Bertin Bukasa Kabuya, Umberto D’Alessandro, et al.
Reference: 
Malaria Journal 2017 16:199, 16 May 2017

As new infections can be prevented by a long acting partner drug to the artemisinins, DHAPQ should be preferred in places as Nchelenge district where transmission is intense while in areas of low transmission intensity AL or MQAS may be used.

Country: 

The malaria testing and treatment landscape in Benin

May 3, 2017 - 15:15 -- Open Access
Tags: 
Author(s): 
Cyprien Zinsou and Adjibabi Bello Cherifath
Reference: 
Malaria Journal 2017 16:174, 26 April 2017

The ACTwatch data has shown the importance of the private sector in terms of access to malaria treatment for the majority of the population in Benin.

Pages

Subscribe to RSS - artemisinin-based combination therapy (ACT)